Ultrasonic tissue characterization in predicting residual ischemia and myocardial viability for patients with acute myocardial infarction

Ultrasound in Medicine and Biology

Volumn 24, Issue 8, 1998, Pages 1107-1120

  Lin, Lung Chun ^a   Wu, Chau Chung ^a   Ho, Yi Lun ^a   Chen, Ming Fong ^a   Liau, Chiau Song ^a   Lee, Yuan Teh ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Myocardial viability; Residual ischemia; Ultrasonic tissue characterization

Indexed keywords

ACOUSTIC WAVE BACKSCATTERING; BLOOD VESSELS; CARDIOLOGY; MEDICAL IMAGING; TISSUE;

ANGIOPLASTY; MYOCARDIAL INFARCTION;

ECHOCARDIOGRAPHY;

ATROPINE; DOBUTAMINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DIAMETER; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STRESS ECHOCARDIOGRAPHY; TISSUE CHARACTERIZATION;

ANGIOPLASTY; ATROPINE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY;

EID: 0032191164     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(98)00104-5     Document Type: Article

References (71)

1. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hinernation optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty . Circulation. 91:1995;663-670.
2. Arnese M, Fioretti PM, Cornel JH, et al. Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol 1994;73:896-890.
3. Baptista J., Arnese M., Roelandt J.R.T.C., et al. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis correlations with dobutamine-atropine stress test . J Am Coll Cardiol. 23:1994;1434-1439.
4. Barilla F., Gheorghiade M., Alam M., Khaja F., Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J. 122:1991;1522-1531.
5. Barzilai B., Vered Z., Mohr G.A., et al. Myocardial ultrasonic backscatter for characterization of ischemia and reperfusion relationship to wall motion . Ultrasound Med Biol. 16:1990;391-398.
6. Bolli R. Myocardial 'stunning' in man. Circulation. 86:1992;1671-1691.
7. Bonow R.O. Identification of viable myocardium. Circulation. 94:1996;2674-2680.
8. Bouki K.P., Lange A., Palka P., et al. Regional variations of ultrasonic integrated backscatter in normal and myopathic left ventricles A new multi-view approach . Eur Heart J. 17:1996;1747-1755.
9. Braunwald E., Kloner R.A. The stunned myocardium prolonged, postischemic ventricular dysfunction . Circulation. 66:1982;1146-1149.
10. Braunwald E., Rutherford J.D. Reversible ischemic left ventricular dysfunction evidence for the "hibernating myocardium." J Am Coll Cardiol. 8:1986;1467-1470.
11. Brown K.A., Weiss R.M., Clements J.P., Wackers F.J.T.H. Usefullness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol. 60:1987;15-19.
12. Carlos M.E., Smart S.C., Wynsen J.C., Sagar K.B. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation. 95:1997;1402-1410.
13. Deedwania P.C., Amsterdam E.A., Vagelos R.H. Evidence-based, cost-effective risk stratification and management after myocardial infarction. Arch Intern Med. 157:1997;273-280.
14. DeWood M.A., Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
15. Eitzman D., Al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 20:1992;559-565.
16. Ellis S.G., Mooney M.R., George B.S., et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenosis after thrombolytic treatment of myocardial infarction. Circulation. 86:1992;1400-1406.
17. Fioretti P.M., Poldermans D., Salustri A., et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 15:1994;355-360.
18. Fitzgerald P.J., McDaniel M.D., Rolett E.L., Strohbehn J.W., James D.H. Two-dimensional ultrasonic tissue characterization backscatter power, endocardial wall motion, and their phase relationship for normal, ischemic, and infarcted myocardium . Circulation. 76:1987;850-859.
19. Garot J., Scherrer-Crosbie M., Monin J.L., et al. Effect of delayed percutaneous transluminal coronary angioplasty of occluded coronary arteries after acute myocardial infarction. Am J Cardiol. 77:1996;915-921.
20. Gibson R.S., Beller G.A., Gheorghiade M., et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction a prospective natural history study . Circulation. 73:1986;1186-1198.
21. Long-term effects of intravenous thrombolytic treatment in acute myocardial infarction final report of the GISSI . Lancet. 1:1987;871-874.
22. Glueck R.M., Mottley J.G., Miller J.G., Sobel B.E., Perez J.E. Effects of coronary artery occlusion and reperfusion on cardiac cycle-dependent variation of myocardial ultrasonic backscatter. Circ Res. 56:1985;683-689.
23. Lange A., Moran C.M., Palka P., et al. The variation of integrated backscatter in human hearts in differing ultrasonic transthoracic views. J Am Soc Echocardiog. 8:1995;830-838.
24. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction- relative efficacy of medical therapy and revascularization. Circulation. 90:1994;2687-2694.
25. Lendenink T., Simoons M.L., Van Es G.A., et al. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation. 92:1995;1110-1116.
26. Lin L.C., Wu C.C., Ho Y.W., et al. Ultrasonic tissue characterization for coronary care unit patients with acute myocardial infarction. Ultrasound Med Biol. 24:1998;187-196.
27. Ling L.H., Pellikka P.A., Mahoney D.W., et al. Atropine augmentation in dobutamine stress echocardiography role and incremental value in a clinical practice setting . J Am Coll Cardiol. 28:1996;551-557.
28. Masuyama T., St. Goar F.G., Tye T.L., et al. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. Circulation. 80:1989;925-934.
29. Masuyama T., Nellessen U., Schnittger I., et al. Ultrasonic tissue characterization with a real time integrated backscatter system in normal and aging human hearts. J Am Coll Cardiol. 14:1989;1704-1708.
30. Meluzin J., Cigarroa C.G., Brickner E., et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarction. Am J Cardiol. 76:1995;877-880.
31. Miketiæ S., Carlsson J., Tebbe U. Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarction. J Am Coll Cardiol. 25:1995;843-847.
32. Milunski M.R., Mohr G.A., Perez J.E., et al. Ultrasonic tissue characterization with integrated backscatter Acute myocardial ischemia, reperfusion, and stunned myocardium in patients . Circulation. 80:1989;491-503.
33. Milunski M.R., Mohr G.A., Wear K.A., et al. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol. 14:1989;462-471.
34. Mottley J.G., Glueck R.M., Perez J.E., Sobel B.E., Miller J.G. Regional differences in the cyclic variation of myocardial backscatter that parallel regional differences in contractile performance. J Acoust Soc Am. 76:1984;1617-1623.
35. Naito J., Masuyama T., Mano T., et al. Validation of transthoracic myocardial ultrasonic tissue characterization comparison of transthoracic and open-chest measurements of integrated backscatter . Ultrasound Med Biol. 21:1995;33-40.
36. O'Brien P.D., O'Brien W.D., Rhyne T.L., Warltier D.C., Sagar K.B. Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness. Circulation. 91:1995;171-175.
37. O'Brien W.D., Sagar K.B., Warltier D.C., Rhyne T.L. Acoustic propagation properties of normal, stunned, and infarcted myocardium morphological and biochemical determinants . Circulation. 91:1995;154-160.
38. Ota T., Craig D.M., Kisslo J. Influences of ultrasonic machine settings, transducer frequency and placement of region of interest on the measurement of integrated backscatter and cyclic variation. Ultrasound Med Biol. 23:1997;1059-1070.
39. Perez J.E., McGill J.B., Santiago J.V., et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol. 19:1992;1154-1162.
40. Piérard L.A., De Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. Indentification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
41. Pitt B. Evaluation of the postinfarct patient. Circulation. 91:1995;1855-1860.
42. Previtali M., Poli A., Lanzarini L., et al. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol. 72:1993;124G-130G.
43. Quiñones M.A. Risk stratification after myocardial infarction. Circulation. 95:1997;1352-1354.
44. Recchia D., Miller J.G., Wickline S.A. Quantification of ultrasonic anisotropy in normal myocardium with lateral gain compensation of two-dimensional integrated backscatter images. Ultrasound Med Biol. 19:1993;497-505.
45. Rijsterborgh H., van der Steen A.F., Krams R., et al. The relationship between myocardial integrated backscatter, perfusion pressure and wall thickness during isovolumic contraction an isolated pig heart study . Ultrasound Med Biol. 22:1996;43-52.
46. Rouleau J.L., Moyé L.A., Pfeffer M.A., et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 328:1993;779-784.
47. Saeian K., Rhyne T.L., Sagar K.B. Ultrasonic tissue characterization for diagnosis of acute myocardial infarction in the coronary care unit. Am J Cardiol. 74:1994;1211-1215.
48. Sagar K.B., Rhyne T.L., Warltier D.C., Pelc L., Wann L.S. Intramyocardial variability in integrated backscatter effect of coronary occlusion and reperfusion . Circulation. 75:1987;436-442.
49. Salustri A., Elhendy A., Garyfallydis P., et al. Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol. 74:1994;853-856.
50. Sawada S.G., Segar D.S., Ryan T., et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 83:1991;1605-1614.
51. Schiller N.B., Shah P.M., Crawford M., et al. Recommendation for the quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 5:1989;358-367.
52. Segar D.S., Brown S.E., Sawada S.G., Ryan T., Feigenbaum H. Dobutamine stress echocardiography correlation with coronary lesion severity as determined by quantitative angiography . J Am Coll Cardiol. 19:1992;1197-1202.
53. Serruys P.W., Simoons M.L., Suryapranata H., et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 7:1986;729-742.
54. Severi S., Underwood R., Mohiaddin R.H., et al. Dobutamine stress effects on regional myocardial blood flow and wall motion . J Am Coll Cardiol. 26:1995;1187-1195.
55. Simoons M.L., Serruys P.W., van den Brand M., et al. Improved survival after early thrombolysis in acute myocardial infarction a randomized trial by the Interuniversity Cardiology Institute in the Netherlands . Lancet. 2:1985;578-582.
56. Smart S.C., Sawada S., Ryan T., et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
57. Smart S.C., Knickelbine T., Stoiber T.R., et al. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation. 95:1997;1394-1401.
58. Stuhlmuller J.E., Skorton D.J., Burns T.L., Melton H.E., Vandenberg B.F. Reproducibility of quantitative backscatter echocardiographic imaging in normal subjects. Am J Cardiol. 69:1992;542-546.
59. SWIFT trial of delayed elective intervention vs. conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ. 302:1991;555-560.
60. Takiuchi S., Ito H., Iwakura K., et al. Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction. Circulation. 97:1998;356-362.
61. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction - results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med. 320:1989;618-627.
62. Yoshida K., Gould K.L. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol. 22:1993;984-997.
63. van der Steen A.F., Rijsterborgh H., Lancee C.T., et al. Influence of data processing on cyclic variation of integrated backscatter and wall thickness in stunned porcine myocardium. Ultrasound Med Biol. 23:1997;405-414.
64. Verani M.S., Roberts R. Preservation of cardiac function by coronary thrombolysis during acute myocardial infarction fact or myth? J Am Coll Cardiol. 10:1987;470-476.
65. Vitale D.F., Bonow R.O., Gerundo G., et al. Alterations in ultrasonic backscatter during exercise-induced myocardial ischemia in humans. Circulation. 92:1995;1452-1457.
66. Wanger R.F., Wear K.A., Perez J.E., et al. Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiers. J Am Coll Cardiol. 25:1995;1706-1711.
67. Watada H., Ito H., Oh H., et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol. 24:1994;624-630.
68. Wickline S.A., Thomas L.J. III, Miller J.G., Sobel B.E., Perez J.E. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation. 72:1985;183-192.
69. Wickline S.A., Thomas L.J. III, Miller J.G., Sobel B.E., Perez J.E. A relationship between ultrasonic integrated backscatter and myocardial contractile function. J Clin Invest. 76:1985;2151-2160.
70. Wickline S.A., Thomas L.J. III, Miller J.G., Sobel B.E., Perez J.E. Sensitive detection of the effects of reperfusion on myocardium by ultrasonic tissue characterization with integrated backscatter. Circulation. 74:1986;389-400.
71. Wu C.C., Ho Y.L., Kao S.L., et al. Dobutamine stress echocardiography for detecting coronary artery disease. Cardiology. 87:1996;244-249.